Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Sensory and Autonomic Neuropathies”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Testing effectiveness (Phase 2)Study completedNCT03126019
What this trial is testing

INCB050465 in Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Lymphoma
Incyte Corporation 126
Testing effectiveness (Phase 2)Study completedNCT01733407
What this trial is testing

L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1

Who this might be right for
Hereditary Sensory and Autonomic Neuropathy Type I
Massachusetts General Hospital 18
Not applicableStudy completedNCT02876939
What this trial is testing

Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy

Who this might be right for
Atunomic Neuropathy
NYU Langone Health 16
Large-scale testing (Phase 3)UnknownNCT06293716
What this trial is testing

CVL237 Tablets for APDS/PASLI

Who this might be right for
PI3K and P110delta Hyperactivation Syndrome
Convalife (Shanghai) Co., Ltd. 35
Early research (Phase 1)Study completedNCT01744704
What this trial is testing

Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers

Who this might be right for
Healthy
Dompé Farmaceutici S.p.A 74
Testing effectiveness (Phase 2)Ended earlyNCT01602315
What this trial is testing

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Novartis Pharmaceuticals 179
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487
What this trial is testing

NDI 1150-101 in Patients With Solid Tumors

Who this might be right for
Solid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT07100938
What this trial is testing

A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
BeiGene 49
Early research (Phase 1)Ended earlyNCT02292225
What this trial is testing

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

Who this might be right for
Lymphocytic Leukemia, ChronicLymphoma, Small Lymphocytic
SecuraBio 3
Not applicableStudy completedNCT03013777
What this trial is testing

A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia

Who this might be right for
DysthymiaAnxiety DisordersFamilial Dysautonomia+2 more
NYU Langone Health 15
Post-approval studies (Phase 4)Study completedNCT01935128
What this trial is testing

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Who this might be right for
Renal Transplant
University of Toledo Health Science Campus 55
Testing effectiveness (Phase 2)Looking for participantsNCT06463028
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Faeth Therapeutics 40
Early research (Phase 1)Study completedNCT01449370
What this trial is testing

Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer

Who this might be right for
Metastatic Solid Tumors
Millennium Pharmaceuticals, Inc. 125
Testing effectiveness (Phase 2)Ended earlyNCT02644122
What this trial is testing

SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
Ezra Cohen 1
Testing effectiveness (Phase 2)Study completedNCT01276379
What this trial is testing

Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab

Who this might be right for
Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 221
Testing effectiveness (Phase 2)Looking for participantsNCT04038502
What this trial is testing

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate CancerBARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2RAD51B, RAD51C, RAD51D, or RAD54L Mutations
VA Office of Research and Development 100
Not applicableStudy completedNCT02108769
What this trial is testing

Yogic Breathing Changes Salivary Components

Who this might be right for
Alzheimer DiseaseNeurodegenerative DiseasesCancer
Medical University of South Carolina 20
Not applicableStudy completedNCT04425200
What this trial is testing

Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting

Who this might be right for
Prostatic Neoplasms
AstraZeneca 205
Early research (Phase 1)Study completedNCT02684032
What this trial is testing

Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Celcuity Inc 141
Large-scale testing (Phase 3)UnknownNCT02055079
What this trial is testing

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Medical University of Vienna 68
Load More Results